Q2 2026 Holdings
Filed 2026-08-14 | 39 holdings | $532.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $55.2M | 1,675,830 | 10.4% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $35.3M | 138,946 | 6.6% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $34.0M | 269,309 | 6.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $33.9M | 455,041 | 6.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $26.6M | 1,215,698 | 5.0% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $26.5M | 562,672 | 5.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $23.8M | 412,961 | 4.5% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $22.6M | 824,043 | 4.2% |
| Natera Inc(NTRA) | COM | 632307104 | $22.3M | 82,181 | 4.2% |
| Incyte Corp(INCY) | COM | 45337C102 | $21.7M | 191,627 | 4.1% |
| Septerna Inc(SEPN) | COM | 81734D104 | $18.0M | 536,152 | 3.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $17.5M | 648,722 | 3.3% |
| Heartflow Inc(HTFL) | COM | 42238D107 | $17.1M | 583,055 | 3.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $16.1M | 1,080,888 | 3.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $14.8M | 276,550 | 2.8% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $13.1M | 106,799 | 2.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $11.7M | 159,384 | 2.2% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $11.3M | 124,778 | 2.1% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $10.6M | 43,182 | 2.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $10.6M | 316,252 | 2.0% |
| Kailera Therapeutics Inc(KLRA) | COMMON STOCK | 482931102 | $10.3M | 468,750 | 1.9% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $9.2M | 940,855 | 1.7% |
| Odyssey Therapeutics Inc(ODTX) | COMMON STOCK | 67613T104 | $8.6M | 457,839 | 1.6% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $8.5M | 31,759 | 1.6% |
| Kardigan Inc(KARD) | COM | 485925101 | $7.5M | 312,500 | 1.4% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $6.7M | 1,695,071 | 1.3% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $6.3M | 471,254 | 1.2% |
| Veradermics Inc(MANE) | COMMON STOCK | 922967104 | $5.6M | 45,856 | 1.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.4M | 244,929 | 1.0% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $4.9M | 6,168,749 | 0.9% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $4.7M | 148,045 | 0.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $3.2M | 32,941 | 0.6% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $2.4M | 318,407 | 0.5% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $2.0M | 520,148 | 0.4% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $1.8M | 1,320,041 | 0.3% |
| Ataibeckley Inc(ATAI) | COM SHS | 04650F101 | $1.0M | 196,858 | 0.2% |
| Metagenomi Therapeutics Inc(MGX) | COM | 59102M104 | $629.5K | 528,993 | 0.1% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $511.0K | 118,279 | 0.1% |
| Faeth Therapeutics Inc(SNSE) | COM NEW | 81728A207 | $368.0K | 14,718 | 0.1% |